IKSUDA THERAPEUTICS LIMITED

• ◆

  Material uncertainty over going concern

  There is a risk that without this further investment, the company will not have sufficient cash to meet its requirements for the next twelve months and the directors have concluded that these circumstances represent a material uncertainty which may cast significant doubt upon the company's ability to continue as a going concern.

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers

Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

1. IKSUDA THERAPEUTICS LIMITED 2018-09-07 → present
2. GLYTHERA LIMITED 2007-11-21 → 2018-09-07

Accounting basis

IFRS

Reporting scope

Standalone (parent only)

Abridged

Yes — abridged accounts (limited disclosure)

Auditor

RSM UK Audit LLP

Audit opinion

Unqualified (clean)

Going concern

Material uncertainty disclosed

“There is a risk that without this further investment, the company will not have sufficient cash to meet its requirements for the next twelve months and the directors have concluded that these circumstances represent a material uncertainty which may cast significant doubt upon the company's ability to continue as a going concern.”

Group structure

1. IKSUDA THERAPEUTICS LIMITED · parent
   1. Glythera Limited 100% · United Kingdom · Not traded since incorporation
   2. Iksuda Inc. 100% · USA · research and development of novel biologics including antibody drug conjugates

Significant events

• “During the year the company raised £20.7m of additional investment funding from key investors, along with a further £15.6m post year end.”
• “On 7 April 2025, the £12m convertible loan was converted into share capital. Further funding was advanced across the period from related parties in line with agreements resulting in an increase in financial liabilities and related accrued interest.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

5

last 12 months

Capital events

6

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.